QUOTE AND NEWS
Benzinga  Sep 12  Comment 
In a report published Friday, Bank of America analyst Curtis Nagle reiterated a Buy rating and $47.00 price target on GNC Holdings Inc (NYSE: GNC). In the report, Bank of America noted, “The supplement industry has one of the steadiest...
TheStreet.com  Sep 12  Comment 
NEW YORK (TheStreet) -- Vitamin retailer Vitamin Shoppe could be considering selling itself after its 52 year old CEO announced that he would retire, Sterne Agee wrote in a note to investors today. WHAT'S NEW: After Vitamin Shoppe announced on...
Market Intelligence Center  Sep 9  Comment 
The patented algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center found a trading opportunity with GNC Holdings Inc. (GNC) that should provide a 5.46% return in just 102 days. Sell one Dec. '14 call at the $37.50...
SeekingAlpha  Aug 27  Comment 
By Josh Arnold: Shares of GNC Holdings (NYSE:GNC) have been on a very wild ride over the past several years. In just the past three years, shares have seen $20 and $60, although they're about in the middle of that range now at $37. The company,...
SeekingAlpha  Aug 26  Comment 
By Asean Century: Investors are starting to get interested in GNC Holdings (NYSE:GNC) again. There are a number of factors driving this interest. For one, shares are down about 36% since the start of the year and wiped out all the gains the stock...
Benzinga  Aug 25  Comment 
Annaly Capital Management, GNC Holdings and Southern Copper are among the companies that have seen insider buying recently. Insiders may sell shares for any number of reasons, but conventional wisdom says that insiders really only buy shares of a...
TheStreet.com  Aug 25  Comment 
NEW YORK (TheStreet) -- GNC Holding's recent naming of Michael Archbold as CEO brings in an experienced and proven industry insider. Archbold is a former chief executive of Talbots and President and COO of Vitamin Shoppe . The 25-year...
SeekingAlpha  Aug 25  Comment 
By James Bjorkman: Let's Give GNC a Checkup GNC Holdings, Inc. (NYSE:GNC), the global specialty retailer of health and wellness products, has seen its stock price skidding for all of 2014. After hitting a high of $60.98 on 27 November 2013,...
Forbes  Aug 20  Comment 
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that...
SeekingAlpha  Aug 14  Comment 
By The Value Investor: Shares of GNC (NYSE:GNC) managed to catch a break after a disastrous year so far. Shares have suffered from worries about a general FDA warning about the safety of supplements, increased competition and customer confusion...




 
TOP CONTRIBUTORS

GNC Holdings, Inc (NYSE:GNC) is a nutritional supplement retailer with more than 7,200 worldwide locations. Each of the company's retail locations sell health and wellness products such as vitamins, minerals, herbal supplements, and diet products. The company sells a large line of products which are sold with the GNC brand name on it.[1]

According to the Nutrition Business Journal, the nutritional supplements industry generated an estimated $28.7B in 2010. It is projected to grow at a Compounded annual growth rate - CAGR of approximately 5.3% until 2015. GNC views the market as being highly fragmented across distributors and producers. GNC believes that this growth and fragmentation provide a significant advantage to a relatively larger operator like GNC.[2]

The company's initial public offering of stock on the NYSE occurred on March 31, 2011. The company offered 22.5M shares each for $16. This was at the midpoint of the $15-$17 initial price range. 6.5M of its 22.5M offered shares were sold by the company's private equity sponsors. This brought the total deal size to $45M. The lead underwriter of the IPO were Goldman Sachs Group (GS), J P Morgan Chase (JPM), Deutsche Bank AG (DB), and Morgan Stanley (MS).[3]

In 2010, GNC reported a total revenue of $1.8B. This was an increase over the 2009 figure of $1.7B. The company's net income in 2010 was $96.6M. This was a 13% decrease from the $111.9 M net income reported for 2009.[4]

References

  1. GNC S-1/A 2011 PROSPECTUS SUMMARY "Our Company" pg 1
  2. GNC S-1/A 2011 PROSPECTUS SUMMARY "Industry Overview" pg 2
  3. Renaissance Capital - IPO Home "Nutritional supplement retailer GNC prices its IPO at $16, within the range" 31 March 2011
  4. GNC S-1/A 2011 PROSPECTUS SUMMARY "Summary Consolidated Financial Data" pg 12-13
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki